| Author (year) | Cases T/C | Age (years) range, mean | Sex M/F | Intervention | Duration | Main outcomes | Experimental group | Control group |
|
Deng and Wang 2000 [18] | 80/80 | NS | T: 59/21, C: 54/26 | MRD (100 mL, po, bid) + basic treatment | Basic treatment | NS | In-hospital mortality, time of kidney recovery |
| Jiang 2012 [27] | 15/15 | T: 77.4, C: 78.6 | T: 10/5, C: 11/4 | Jishengshenqiwan pills (90–110 g, po, qd) + basic treatment + CRRT | Basic treatment + CRRT | 2 weeks | In-hospital mortality |
| Li 2014 [31] | 49/49 | T: 42.2, C: 45.96 | T: 28/21, C: 25/24 | MRD (50 mL, po, bid) + basic treatment + RRT | Basic treatment + RRT | 14 days | Overall efficacy, time of kidney recovery |
|
Luo and Yuan 2013 [30] | 20/20 | T: 30–53, C: 31–59 | T: 13/7, C: 11/9 | MRD (200 mL, pr, qd) + basic treatment | Basic treatment | 15 days | Overall efficacy |
| Pan et al. 2009 [24] | 22/20 | T: 45, C: 47 | T: 13/9, C: 12/8 | XBJ injection (50 mL, ivgtt, bid) + basic treatment + RRT | Basic treatment + RRT | 15 days | In-hospital mortality, overall efficacy, time of kidney recovery |
| Ru 2013 [28] | 38/38 | T: 43.83, C: 42.70 | T: 22/16, C: 21/17 | XBJ injection (50 mL, ivgtt, bid) + basic treatment + RRT | Basic treatment + RRT | 2 weeks | In-hospital mortality, overall efficacy |
| Sun et al. 2001 [19] | 21/22 | T: 38.6, C: 35.7 | T: 14/7, C: 15/7 | Huangqi injection (20–30 mL, ivgtt, qd) + basic treatment + RRT | Basic treatment + RRT | 2 weeks | In-hospital mortality |
| Sun et al. 2007 [22] | 34/30 | T: 38.2, C: 39.1 | T: 18/16, C: 17/13 | Modified XBJ injection (100 mL, ivgtt, qd) + basic treatment + RRT | Basic treatment + RRT | NS | In-hospital mortality, overall efficacy, time of kidney recovery |
| Wang 2010 [25] | 30/30 | T: 54.67, C: 54.7 | T: 17/13, C: 18/12 | MRD (100 mL, pr, qd) + basic treatment | Basic treatment | 1 week | In-hospital mortality, overall efficacy |
|
Wen and Liu 2003 [20] | 62/62 | T: 17–65, C: 16–63 | T: 41/21, C: 39/23 | MRD (100 mL, po, qd) + basic treatment + RRT | Basic treatment + RRT | 2 weeks | In-hospital mortality, overall efficacy, time of kidney recovery |
| Wu et al. 2014 [32] | 26/22 | T: 65, C: 62 | T: 20/6, C: 15/7 | Dongchongxiacao capsules (2-3 g, po, tid) + basic treatment | Basic treatment | 2 weeks | Time of kidney recovery |
| Yang 2007 [23] | 34/30 | T: 38.2, C: 42.70 | T: 18/16, C: 17/13 | XBJ injection (50 mL, ivgtt, bid) + basic treatment + RRT | Basic treatment + RRT | NS | In-hospital mortality, overall efficacy, time of kidney recovery |
| Yu et al. 2010 [26] | 25/27 | T: 68.49, C: 69.37 | T: 16/9, C: 19/8 | Qishen Huoxue granule (10 g, po, tid) + CRRT | CRRT | 14 days | In-hospital mortality |
|
Zhang and Mao 2003 [21] | 33/32 | T: 38.12, C: 37.56 | T: 25/8, C: 23/9 | MRD (2–4 g, po, tid) + basic treatment + RRT | Basic treatment + RRT | 4 weeks | In-hospital mortality, overall efficacy, time of kidney recovery |
|
Zhu and Tang 2014 [29] | 41/41 | T: 49.2, C: 48.90 | T: 28/13, C: 26/15 | XBJ injection (50 mL, ivgtt, bid) + basic treatment + RRT | Basic treatment + RRT | 7 days | In-hospital mortality, overall efficacy, time of kidney recovery |
|
|